Director of Innovative Cancer Medicine Institute
- Director of Innovative Cancer Medicine Institute and Professor Emeritus, Department of Hematology-Oncology Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea
- Director of Medical Nano Element Development Center at the Ministry of Health and Welfare in Korea
- Associate Editor of the Journal of Thoracic Oncology, and Editorial Board Member of the Asia-Pacific Journal of Clinical Oncology.
- Board of Directors in the International Association for the Study of Lung Cancer (IASLC), Chairman of the 4th Asia Pacific Lung Cancer Conference (APLCC), Chairman of the Korean Association for Clinical Oncology (KACO), and member of the Cancer Treatment Policy Committee of the Korean Medical Association (KMA). He has authored/co-authored over 300 publications in the peer-review journals.
- Professor Park’s main research interests include thoracic and head & neck oncology, early clinical trials and the development of experimental therapeutics. Professor Park has been working at Samsung Medical Center since 1994 and was the Chair of Lung Cancer Committee of the Korean Cancer Study Group from 2003 to 2007
(Speaker’s CV as of event date September 24, 2021)
PC-PH-103430 / March 2022